OriPeutic BioServices HELPS, YOU NAVIGATE THE EARLY STAGE CLINICAL LANDSCAPE FROM PRECLINICAL IND SUBMISSION TO FIRST-IN-HUMAN PHASE 1 TRIAL AND BEYOND.

With the increasing need for professional support to bring novel therapeutics to patients worldwide, we have amassed a team of early-stage / clinical experts to support you with every step. We know it takes a team to bring new therapies to market. Our consultants bring 20-30+ years of drug development experience – we have walked in your shoes and understand your challenges. We see the big picture – from translational medicine, protocol development, trial design, and PIND/IND strategy to the first dose and beyond.

RELY ON OriPeutic Bio-Services TO GUIDE YOU THROUGH THE PROCESS TO PROPERLY POSITION YOUR THERAPEUTIC ASSET FOR PROTOCOL DEVELOPMENT, IND APPROVAL, AND INTO THE CLINIC.

OriPeutic BioServices provides the guidance, expertise, and support to help you get your medicine to patients faster, including:

• Acting Interim Chief Medical Officer

• Protocol and Trial Design

• Clinical Operations

• Clinical Pharmacology

• Regulatory Strategy (pIND/IND)

• Pharmacovigilance/Safety Monitoring

• Data Management

• CRO/CDMO Selection and Management

• Due Diligence, Asset evaluation, Scouting, Licensing

SUSTAINABLE RESULTS.

Our seasoned and highly credentialed consultants, who have years of drug development experience and have worked for or run their own biotech/sponsor/CRO organizations, are ready to work with you. We share industry best practices to help you develop practical and efficient early-stage / clinical programs.